Related Experiment Video
Updated: Jul 15, 2026

09:07
Techniques of Endoscopic Ossiculoplasty
Published on: January 26, 2024
Relationship between pediatric obesity and otitis media with effusion
Jong Bin Kim1, Dong Choon Park, Chang Il Cha
1Department of Otorhinolaryngology, College of Medicine, Kyung Hee University, Seoul, Korea.
Archives of Otolaryngology--Head & Neck Surgery
|April 18, 2007
Summary
Childhood obesity may be linked to otitis media with effusion. This study found higher BMI and cholesterol in children with the condition, suggesting a potential association.
Area of Science:
- Pediatric Health
- Otolaryngology
- Metabolic Syndrome
Background:
- Otitis media with effusion (OME) is a common pediatric condition.
- Obesity is a growing public health concern in children.
- The relationship between pediatric obesity and OME requires further investigation.
Purpose of the Study:
- To explore the association between pediatric otitis media with effusion and obesity.
- To analyze body mass index (BMI), serum triglyceride (TG), and total cholesterol (TC) levels in children with and without OME.
Main Methods:
- A prospective, nonrandomized case-control study was conducted at a university-affiliated hospital.
- 155 children (2-7 years) with OME (experimental group) and 118 children without OME (control group) were included.
- Groups were compared based on BMI, serum TG, and TC concentrations.
Main Results:
- Children with OME had significantly higher mean BMI and TC levels compared to controls.
- Serum TG levels did not significantly differ between the groups.
- Ventilation tube insertion frequency did not significantly vary between obese and non-obese subgroups.
Conclusions:
- Childhood obesity may be associated with the occurrence of otitis media with effusion.
- Elevated BMI and TC levels in children with OME suggest a potential link.
- Further research is needed to elucidate the underlying mechanisms.
Related Concept Videos
Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Tonsillitis I: Introduction
Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
Etiology
Three primary contributing factors have been identified.
Pneumothorax II: Pathophysiology
Pneumothorax means the presence of air in the pleural space — the thin potential gap between the visceral and parietal pleura. This condition disrupts the normal pressure balance that keeps the lungs inflated, leading to partial or complete collapse of the affected lung.Normal physiologyUnder normal conditions, the pleural space maintains a slightly negative intrapleural pressure, which keeps the lungs expanded against the chest wall. This negative pressure creates a delicate balance between...
